EU agency prepares to publish draft guideline on biosimilar MAbs
This article was originally published in SRA
Executive Summary
The long-awaited draft guideline on developing biosimilar monoclonal antibodies is due to be published this week after it was adopted by the European Medicines Agency's scientific committee, the CHMP, at its 15-18 November meeting1.